Rodenticides; Product Cancellation Order

Notice. Citation: "74 FR 50193" Document Number: "EPA-HQ-OPP-2006-0955; FRL-8438-6" Page Number: "50193" "Notices" SUMMARY: This notice announces EPA's order for the cancellation of registrations, voluntarily requested by the registrants and accepted by t...

Full description

Saved in:
Bibliographic Details
Published inThe Federal Register / FIND Vol. 74; no. 188; p. 50193
Format Report
LanguageEnglish
Published Washington Federal Information & News Dispatch, LLC 30.09.2009
Online AccessGet full text

Cover

Loading…
More Information
Summary:Notice. Citation: "74 FR 50193" Document Number: "EPA-HQ-OPP-2006-0955; FRL-8438-6" Page Number: "50193" "Notices" SUMMARY: This notice announces EPA's order for the cancellation of registrations, voluntarily requested by the registrants and accepted by the Agency, of certain rodenticide products containing the pesticides bromadiolone, bromethalin, cholecalciferol, diphacinone (and its sodium salt), warfarin (and its sodium salt), and zinc phosphide, pursuant to section 6(f)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended. This cancellation order follows a December 24, 2008 Federal Register Notice of Receipt of Requests from several registrants to voluntarily cancel certain bromadiolone, bromethalin, cholecalciferol, diphacinone (and its sodium salt), warfarin (and its sodium salt), and zinc phosphide product registrations. These are not the last bromadiolone, bromethalin, cholecalciferol, diphacinone (and its sodium salt), warfarin (and its sodium salt), and zinc phosphide products registered for use in the United States. In the December 24, 2008 notice, EPA indicated that it would issue an order cancelling the products unless the Agency received substantive comments within the 180-day comment period that would merit its further review of these requests, or unless the registrants withdrew their requests within this period. The Agency did not receive any comments on the notice. Further, the registrants did not withdraw their requests. Accordingly, EPA hereby issues in this notice a cancellation order granting the requested cancellations. Any distribution, sale, or use of the bromadiolone, bromethalin, cholecalciferol, diphacinone (and its sodium salt), warfarin (and its sodium salt), and zinc phosphide products subject to this cancellation order is permitted only in accordance with the terms of this order, including any existing stocks provisions.
ISSN:0097-6326
2167-2520